160 related articles for article (PubMed ID: 27752823)
1. Acute promyelocytic leukaemia is highly frequent among acute myeloid leukaemias in Brazil: a hospital-based cancer registry study from 2001 to 2012.
Thuler LCS; Pombo-de-Oliveira MS
Ann Hematol; 2017 Mar; 96(3):355-362. PubMed ID: 27752823
[TBL] [Abstract][Full Text] [Related]
2. Outcome of Adolescents and Young Adults Compared With Pediatric Patients With Acute Myeloid and Promyelocytic Leukemia.
Nasir SS; Giri S; Nunnery S; Martin MG
Clin Lymphoma Myeloma Leuk; 2017 Feb; 17(2):126-132.e1. PubMed ID: 27836483
[TBL] [Abstract][Full Text] [Related]
3. Immunophenotype distinction between acute promyelocytic leukaemia and CD15- CD34- HLA-DR- acute myeloid leukaemia with nucleophosmin mutations.
Ferrari A; Bussaglia E; Úbeda J; Facchini L; Aventin A; Sierra J; Nomdedéu JF
Hematol Oncol; 2012 Sep; 30(3):109-14. PubMed ID: 21812014
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a machine-learning model based on laboratory parameters for the prediction of acute leukaemia subtypes: a multicentre model development and validation study in France.
Alcazer V; Le Meur G; Roccon M; Barriere S; Le Calvez B; Badaoui B; Spaeth A; Kosmider O; Freynet N; Eveillard M; Croizier C; Chevalier S; Sujobert P
Lancet Digit Health; 2024 May; 6(5):e323-e333. PubMed ID: 38670741
[TBL] [Abstract][Full Text] [Related]
5. Comparing the epidemiology, clinical characteristics and prognostic factors of acute myeloid leukemia with and without acute promyelocytic leukemia.
Kamath GR; Tremblay D; Coltoff A; Caro J; Lancman G; Bhalla S; Najfeld V; Mascarenhas J; Taioli E
Carcinogenesis; 2019 Jul; 40(5):651-660. PubMed ID: 30715157
[TBL] [Abstract][Full Text] [Related]
6. High frequency of acute promyelocytic leukemia in northwest Iran.
Ziaei JE
Asian Pac J Cancer Prev; 2004; 5(2):188-9. PubMed ID: 15244523
[TBL] [Abstract][Full Text] [Related]
7. Acute promyelocytic leukaemia: epidemiology and risk factors. A report of the GIMEMA Italian archive of adult acute leukaemia. GIMEMA Cooperative Group.
Pulsoni A; Stazi A; Cotichini R; Allione B; Cerri R; Di Bona E; Nosari AM; Pagano L; Recchia A; Ribersani M; Rocchi L; Veneri D; Visani G; Mandelli F; Mele A
Eur J Haematol; 1998 Nov; 61(5):327-32. PubMed ID: 9855248
[TBL] [Abstract][Full Text] [Related]
8. Identification of the t(15;17) in AML FAB types other than M3: evaluation of the role of molecular screening for the PML/RARalpha rearrangement in newly diagnosed AML. The Medical Research Council (MRC) Adult Leukaemia Working Party.
Allford S; Grimwade D; Langabeer S; Duprez E; Saurin A; Chatters S; Walker H; Roberts P; Rogers J; Bain B; Patterson K; McKernan A; Freemont P; Solomon E; Burnett A; Goldstone A; Linch D
Br J Haematol; 1999 Apr; 105(1):198-207. PubMed ID: 10233384
[TBL] [Abstract][Full Text] [Related]
9. Survival and risk factors for mortality in pediatric patients with acute myeloid leukemia in a single reference center in low-middle-income country.
Lins MM; Mello MJG; Ribeiro RC; De Camargo B; de Fátima Pessoa Militão de Albuquerque M; Thuler LCS
Ann Hematol; 2019 Jun; 98(6):1403-1411. PubMed ID: 30915498
[TBL] [Abstract][Full Text] [Related]
10. Continuing high early death rate in acute promyelocytic leukemia: a population-based report from the Swedish Adult Acute Leukemia Registry.
Lehmann S; Ravn A; Carlsson L; Antunovic P; Deneberg S; Möllgård L; Derolf AR; Stockelberg D; Tidefelt U; Wahlin A; Wennström L; Höglund M; Juliusson G
Leukemia; 2011 Jul; 25(7):1128-34. PubMed ID: 21502956
[TBL] [Abstract][Full Text] [Related]
11. Radar plots facilitate differential diagnosis of acute promyelocytic leukemia and NPM1+ acute myeloid leukemia by flow cytometry.
Gupta M; Jafari K; Rajab A; Wei C; Mazur J; Tierens A; Hyjek E; Musani R; Porwit A
Cytometry B Clin Cytom; 2021 Jul; 100(4):409-420. PubMed ID: 33301193
[TBL] [Abstract][Full Text] [Related]
12. Influence of body mass index on incidence and prognosis of acute myeloid leukemia and acute promyelocytic leukemia: A meta-analysis.
Li S; Chen L; Jin W; Ma X; Ma Y; Dong F; Zhu H; Li J; Wang K
Sci Rep; 2017 Dec; 7(1):17998. PubMed ID: 29269861
[TBL] [Abstract][Full Text] [Related]
13. Acute promyelocytic leukaemia in children.
Gregory J; Feusner J
Best Pract Res Clin Haematol; 2003 Sep; 16(3):483-94. PubMed ID: 12935964
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of PG-M3 antibody in the diagnosis of acute promyelocytic leukaemia.
Gupta SK; Sazawal S; Mahapatra M; Saxena R
Eur J Clin Invest; 2010 Oct; 40(10):960-2. PubMed ID: 20701624
[TBL] [Abstract][Full Text] [Related]
15. Acute promyelocytic leukaemia is characterized by stable incidence and improved survival that is restricted to patients managed in leukaemia referral centres: a pan-Canadian epidemiological study.
Paulson K; Serebrin A; Lambert P; Bergeron J; Everett J; Kew A; Jones D; Mahmud S; Meloche C; Sabloff M; Sharif I; Storring J; Turner D; Seftel MD
Br J Haematol; 2014 Sep; 166(5):660-6. PubMed ID: 24780059
[TBL] [Abstract][Full Text] [Related]
16. Clinico-pathological profile of acute promyelocytic leukaemia at Al-Amal Oncology-Haematology Centre, Qatar.
Ibrahim FA; Yassin MA; El-Ayoubi HR; Alhiji IA; Albinali AS; Almansour SM; Qafoud FM
East Mediterr Health J; 2010 Sep; 16(9):958-65. PubMed ID: 21218723
[TBL] [Abstract][Full Text] [Related]
17. Acute promyelocytic leukemia is a distinct subset of acute myelocytic leukemia with unique clinicopathologic characteristics including longer duration of relapse free survival: experience in 13 cases.
Lee KH; Kim DH; Lee JS; Suh CW; Kim SW; Kim SB; Lee JH; Doh BS; Chi HS; Lee MS
J Korean Med Sci; 1994 Dec; 9(6):437-43. PubMed ID: 7786438
[TBL] [Abstract][Full Text] [Related]
18. Infectious complications in patients with acute promyelocytic leukaemia treated with the AIDA regimen.
Girmenia C; Lo Coco F; Breccia M; Latagliata R; Spadea A; D'Andrea M; Gentile G; Micozzi A; Alimena G; Martino P; Mandelli F
Leukemia; 2003 May; 17(5):925-30. PubMed ID: 12750707
[TBL] [Abstract][Full Text] [Related]
19. [An epidemiological investigation of adult acute leukemia in Fujian Province in 2010].
Clinical Collaborative Group, Hematological Branch of Fujian Medical Association
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):902-5. PubMed ID: 23363744
[TBL] [Abstract][Full Text] [Related]
20.
Zhou J; Gou H; Zhang L; Wang X; Ye Y; Lu X; Ying B
DNA Cell Biol; 2019 Nov; 38(11):1374-1386. PubMed ID: 31599655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
